Syntheses of Analgesics. III
نویسندگان
چکیده
منابع مشابه
Lanthanide(III) oxalatophosphonates: syntheses, crystal structures and luminescence properties.
By the introduction of oxalate as the second ligand, five new lanthanide oxalatophosphonate hybrids with a 2D layered structure, namely, [Ln(H2L)(C2O4)(H2O)]·2H2O [Ln = Nd (1), Sm (2), Eu (3), Tb (4), Dy (5), H3L = H2O3PCH2NCH2(CH2CH2OPO2H)], have been hydrothermally synthesized and structurally characterized by X-ray single-crystal diffraction, X-ray powder diffraction, infrared spectroscopy, ...
متن کاملOpioid Analgesics
Intensive research on the neurobiology of pain over the past two decades has revealed many receptors, ion channels and enzymes with potential as novel targets for development of a new generation of analgesic agents. However, despite large investment in preclinical and clinical development of small molecules and biologics as potential novel pain therapeutics, very few have reached the clinic. He...
متن کاملTopical analgesics.
BACKGROUND AND OBJECTIVES Pain treatment involves the usage of common and opioid analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs) and adjuvant analgesics. Traditionally, these drugs are administered systemically or into the neuraxis. However, when analgesics are applied through these pathways, they are associated with significant side effects, which can hinder its use. Topical administ...
متن کاملSyntheses and Co-Fluorescence of Complexes of Eu (III)/Gd (III) with Thienyltrifluoroacetonate, Terephthalic Acid and Phenanthroline
A series of complexes of europium (III)/gadolinium (III) with 2-thienyltrifluoroacetonate (HTTA), terephthalic acid (TPA) and phenanthroline (Phen) were synthesized by coprecipitation. The resulting complexes including Eu2(TPA)(TTA)4Phen2, Eu1.4Gd0.6(TPA)(TTA)4Phen2, Eu1.0Gd1.0(TPA)(TTA)4Phen2 and Eu0.8Gd1.2(TPA)(TTA)4Phen2 were characterized by elemental analysis, IR spectroscopy and thermal s...
متن کاملBottlenecks in the development of topical analgesics: molecule, formulation, dose-finding, and phase III design
Topical analgesics can be defined as topical formulations containing analgesics or co-analgesics. Since 2000, interest in such formulations has been on the rise. There are, however, four critical issues in the research and development phases of topical analgesics: 1) The selection of the active pharmaceutical ingredient. Analgesics and co-analgesics differ greatly in their mechanism of action, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: YAKUGAKU ZASSHI
سال: 1964
ISSN: 0031-6903,1347-5231
DOI: 10.1248/yakushi1947.84.5_405